logo

Corporate News

Share

Regeneron Pharmaceuticals Inc. (REGN) and Sanofi said that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP recommended Dupixent be approved as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe chronic rhinosinusitis with nasal...

Merck (MRK), known as MSD outside the U.S. and Canada, announced Friday that the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO (in combination with other antiretroviral agents) and DELSTRIGO (as a complete regimen) that expand their indications...

McDermott International Inc. (MDR) said that it is exploring strategic alternatives for Lummus Technology, while maintaining the strategic rationale of engineering, procurement and construction. In the pre-market trade, MDR is trading at $2.30, up $0.73 or 46.50 percent. McDermott has retained...

Shares of eve Sleep plc (EVE.L) were plunging around 36 percent in London trading after the manufacturer of sleep products announced Friday that the early stage merger talks with Simba Sleep Ltd. have ended. The company also issued its trading update, noting that overall trading has been more challenging...

facebook-092019.jpg Facebook announced that its fundraising tools have helped to raise over $2 billion for non profit and personal causes since its launch in 2015. According to the social media giant, around $1 billion of funds came exclusively from birthday fundraisers as people dedicated their special day to support important causes. Over 45 million people have donated to or created a fundraiser on Facebook.

Shares of Serco Group plc (SRP.L) were gaining around 3 percent in the morning trading in London after the provider of public services announced that it was awarded a contract worth 450 million pounds for Northern Isles Ferry Services. The company has been selected as the preferred bidder to continue...

elanco-sept20.jpg Shares of Elanco Animal Health Inc. (ELAN) are down nearly 28 percent from a high of $37.61 recorded on September 27, 2018.

Astellas Pharma Inc. (ALPMY, ALPMY) and FibroGen, Inc. (FGEN) reported the approval of Evrenzo (generic name: roxadustat) in Japan for the treatment of anemia associated with chronic kidney disease in dialysis patients. This is the first approval for roxadustat through the Astellas and FibroGen association. Roxadustat...

City of London Investment Trust Plc (CTY.L) reported Friday that its fiscal 2019 net return before taxation was 43.69 million pounds, down from 89.76 million pounds a year ago. Return per ordinary share was 11.66 pence, down from 25.58 pence a year ago. Revenue net return before taxation was 73.20...

Responding to UK's competition watchdog Thursday announcement that JD Sports Fashion plc's (JD.L) 90 million pounds Footasylum deal may hurt competition, Sports Direct International Plc. (SPD.L) said Friday that it has consistently aimed to provide the widest range of products at attractive prices. Sports...

Keller Group plc (KLR.L) announced the resignation of Alain Michaelis as Chief Executive Officer, effective 30 September 2019, by mutual agreement with the Board. Michael Speakman, Chief Financial Officer, will become Interim CEO. Mark Hooper, Financial Controller, will become Interim CFO. The Group...

Investec plc (INVP.L) Friday said it expects first-half adjusted earnings per share to be 4 percent to 7 percent lower than prior period In its pre-close trading update ahead of its first-half results, the company projects group adjusted operating profit to be slightly behind the prior period due...

Smiths Group plc (SMIN.L) reported an underlying headline operating profit growth of 4 percent for the year ended 31 July 2019. Underlying revenue growth of 3% was in line with the Group's expectations. The Group said all divisions delivered growth, except for Smiths Detection where some large orders...

National Grid plc (NG.L, NGG) said that an Investor teach-in, which will be conducted by the company to provide a detailed understanding of its US regulated businesses, will highlight the company's growth prospects in the US, where asset growth is expected to be over 8% for the medium-term. The US...

Royal Bank of Scotland Group plc (RBS, RBS.L) announced Friday the appointment of Alison Rose as Executive Director and Chief Executive Officer, effective November 1. Rose, currently Deputy CEO NatWest Holdings and CEO Commercial and Private Banking, succeeds Ross McEwan, who will formally step down...

Follow RTT
>